A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
University of Colorado, Denver
EMD Serono
Regor Pharmaceuticals Inc.
MOMA Therapeutics
Eli Lilly and Company
Eli Lilly and Company
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
AstraZeneca
Incyte Corporation
Mersana Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Nammi Therapeutics Inc
Fate Therapeutics
Conjupro Biotherapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Conjupro Biotherapeutics, Inc.
Cogent Biosciences, Inc.
GlaxoSmithKline
SystImmune Inc.
M.D. Anderson Cancer Center
Institut Paoli-Calmettes
Orano Med LLC
Atavistik Bio, Inc
NiKang Therapeutics, Inc.
Alterome Therapeutics, Inc.
ViroMissile, Inc.
Myeloid Therapeutics
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Poseida Therapeutics, Inc.
IDEAYA Biosciences
MacroGenics
Avacta Life Sciences Ltd
SystImmune Inc.
SN BioScience
M.D. Anderson Cancer Center
Eli Lilly and Company
Shanghai Best-Link Bioscience, LLC
University of Washington
Fusion Pharmaceuticals Inc.
M.D. Anderson Cancer Center
OncoNano Medicine, Inc.
National Institutes of Health Clinical Center (CC)
Risen (Suzhou) Pharma Tech Co., Ltd.
NextCure, Inc.
Nuvation Bio Inc.